Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
26.34
+1.80 (7.33%)
At close: Sep 18, 2025, 4:00 PM EDT
25.97
-0.37 (-1.40%)
After-hours: Sep 18, 2025, 5:48 PM EDT

Vera Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
1,6812,678683535569-
Upgrade
Market Cap Growth
-24.08%291.87%27.69%-5.87%--
Upgrade
Enterprise Value
1,2022,380553433482-
Upgrade
Last Close Price
26.3442.2915.3819.3526.72-
Upgrade
PB Ratio
3.594.646.726.968.17-
Upgrade
P/TBV Ratio
3.594.646.726.968.17-
Upgrade
Debt / Equity Ratio
0.170.100.530.410.07-
Upgrade
Quick Ratio
16.7225.417.234.4810.3622.36
Upgrade
Current Ratio
17.0325.677.714.9110.7322.55
Upgrade
Return on Equity (ROE)
-54.84%-44.83%-107.50%-121.58%-54.43%-198.65%
Upgrade
Return on Assets (ROA)
-30.24%-25.14%-41.54%-52.81%-31.09%-102.70%
Upgrade
Return on Capital (ROIC)
-31.85%-26.55%-48.38%-62.19%-34.47%-114.19%
Upgrade
Earnings Yield
-12.98%-5.68%-14.05%-16.64%-5.74%-
Upgrade
FCF Yield
-11.10%-5.07%-13.50%-12.64%-4.17%-
Upgrade
Buyback Yield / Dilution
-24.93%-29.55%-60.73%-97.76%-4099.14%-8.34%
Upgrade
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q